A carregar...

A randomized trial of estrogen or raloxifene during postmenopausal weight loss: Adiposity and cardiometabolic outcomes

OBJECTIVE: Estrogen-based hormone therapy (HT) attenuates abdominal fat gain after menopause, but whether HT improves abdominal fat loss during weight loss is unknown. We hypothesized that HT or a selective estrogen receptor modulator (raloxifene) would augment reductions in abdominal visceral fat d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Van Pelt, R.E., Gozansky, W.S., Wolfe, P., Kittelson, J.M., Jankowski, C.M., Schwartz, R.S., Kohrt, W.M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3968229/
https://ncbi.nlm.nih.gov/pubmed/24311443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.20653
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!